Articles On Monash IVF Group (ASX:MVF)

  Highlights The ASX 200 Today ended lower after a series of corporate earnings updates Consumer staples, healthcare, and utilities were the main sectors under pressure Mixed performance recorded among the big four banks, w...

  Highlights Australian market moves lower with mixed performance across mining, banking, and tech sectors Global focus remains on central bank policy outlook as investors await key speeches from US Federal Reserve Major As...

The ASX healthcare sector fell ~9.9% over past five days while broader market was up 1.3% in ‘disastrous week’ for sector Sector’s largest stock CSL led dips in tough reporting season, down 17% on Tuesday in its biggest ever daily fall Son...

The S&P/ASX 200 Index (ASX: XJO) is out of form and on course to end the week in the red. In afternoon trade, the benchmark index is down 0.35% to 8,986.4 points. Four ASX shares that are falling more than most today are listed below. H...

The Monash IVF Ltd (ASX: MVF) share price tanked 18% to an intraday low of 66 cents per share on Friday. The share price plunge came after the in-vitro fertilisation provider revealed its full-year FY25 results. The S&P/ASX 300...

An independent review by Monash IVF Group (ASX: MVF) of two separate incidents of embryo mix-ups in Brisbane and Melbourne have found human error and IT system limitations as causes for the failures. While the full report prepared by Fiona...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

Highlights: Iluka Resources sees rising short positions despite strong quarterly output JB Hi-Fi short interest hits multi-month high on valuation concerns Energy and lithium sectors remain focal points for short sellers...

ASX small-cap stocks have the potential to beat the market by a wide margin.  Compared to large-cap stocks, small-cap stocks have higher growth potential. Due to their size, they can grow much more rapidly. On the ASX, a small-cap stock...

S&P/ASX 200 Index (ASX: XJO) shares closed 0.59% higher at 8,589.2 points on Thursday. Here are three ASX shares that the experts think are undervalued at their current share prices. 3 ASX shares with plenty of upside: experts...

S&P/ASX All Ords Index (ASX: XAO) shares are up 0.069% to 8,832.5 points on Tuesday. In a series of new notes, top broker Morgans has revealed a buy rating on four ASX All Ords shares from different market sectors. Two of them ma...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

UBS reckons healthcare will fare better than any other ASX sector Bell Potter says Monash IVF has fertile recovery prospects Telix wins FDA usage expansion for prostate cancer imaging     Financial giant UBS has declared that enough is e...

Highlights CETTIRE LIMITED and BANNERMAN ENERGY LIMITED led the gains in the ASX300 VULCAN STEEL LIMITED and IONEER LIMITED experienced notable declines Daily movements reflect strong activity in resources, technology, and i...

Highlights Monash IVF Group Ltd operates in the healthcare sector and is part of the ASX 300 Nufarm Ltd is an agriculture-focused entity, listed on the ASX 100 Zip Co Ltd is a fintech company listed on the All Ordinaries...

Highlights Energy stocks lifted by oil rally and major M&A activity Gold miners fell despite rising bullion prices Broader market finishes nearly unchanged amid uncertainty The Australian Securities Exchange (ASX) concluded th...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

ASX heath sector falls 1.1% over past five days, while broader markets flat as Middle East tensions flare Cochlear downgrades full-year profit expectations but launches a world first  Monash IVF head Michael Knaap resigns after another emb...

The Monash IVF Group Ltd (ASX: MVF) share price is up 8% after the fertility business announced the departure of its CEO. Monash IVF provides a number of different fertility services for patients to help them have a baby. Monash IVF CEO res...

Monash IVF Group Ltd (ASX: MVF) shares are bouncing back strongly on Thursday. In afternoon trade, the embattled fertility treatment company's shares are up 9% to 66 cents. Though, this changes very little on a 12-month basis, with its shar...

The S&P/ASX 200 Index (ASX: XJO) is on course to record the smallest of gains on Thursday. In afternoon trade, the benchmark index is up slightly to 8,592.5 points. Four ASX shares that are rising more than most today are listed below....

Highlights ASX 200 lifted by energy and mining gains amid US-China trade progress Monash IVF rebounds after recent decline linked to operational incident Corporate updates from Zip, Johns Lyng, Fletcher Build...

Highlights Aluminium and copper edge higher amid broader commodity strength Service Stream secures NBN FTTP rollout contract extension Small caps including Johns Lyng Group and Monash IVF rise early The...

Leading broker Macquarie has tipped an eyewatering 106% upside for ASX All Ords healthcare stock Monash IVF Group Ltd (ASX: MVF).  This comes after the IVF provider's shares suffered a 26% decline yesterday. The ASX All Ords healthcare...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Overseas markets were mixed overnight, with US indices tracking higher, led by Tesla...

Highlights ASX 200 finishes at a new all-time high amid strength in financials and resources Commonwealth Bank closes at record levels alongside gains in Westpac, NAB, and ANZ Lithium and tech names like Pilbara Minerals and...

Highlights ASX 200 lifts as Australian dollar strengthens and global sentiment steadies Monash IVF Group (ASX:MVF) shares fall following disclosure of an embryo error Market awaits outcome of renewed US-China trade negotiati...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

ASX health stocks up 0.57% over past week, while the broader market is up 0.35%  Wave of capital raisings as ASX-listed healthcare firms seek to strengthen their balance sheets Monash IVF’s woes continue with company downgrading FY25 blami...

Yesterday was a forgettable day for Monash IVF Group Ltd (ASX: MVF) shareholders.  The ASX All Ords healthcare company's shares fell 12% after the fertility treatment firm downgraded its guidance for FY 2025. The company now expects it...

Highlights: ASX 200 lifted following RBA’s cash rate cut, led by real estate and tech stocks Financials and consumer discretionary sectors recorded upward momentum Resources and energy shares, especially gold, trailed amid g...

The S&P/ASX 200 Index (ASX: XJO) is having a decent session on Tuesday. In afternoon trade, the benchmark index is up 0.4% to 8,326.8 points. Four ASX shares that have failed to follow the market higher today are listed below. Here's...

With FY 2024 annual reports mostly done and dusted, Macquarie has identified 7 companies sitting on excess franking credits, piles of excess cash, and the capacity to increase their dividend yields. Franking credits are the tax already p...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

Monash IVF shares have been under pressure lately.  In April, it was revealed that an Australian woman had unknowingly given birth to a stranger's baby, after her fertility clinic accidentally implanted another woman's embryos into her....

ASX falls 0.82pc, led down by energy and healthcare stocks Gold rises to all-time high at US$3,215 per ounce Oil falls to levels not seen since April 2020, at height of Covid-19 pandemic Despite pulling back on Tuesday, gold prices have h...

ASX heath sector falls 4%, while broader markets down 0.79% for the same period as US tariffs  Monash IVF falls after woman gives birth to a baby that was not hers after mistakenly transferred wrong embryo Imricor starts its European trial...

The S&P/ASX 200 Index (ASX: XJO) recovery has run out of steam on Friday. In afternoon trade, the benchmark index is down 1.45% to 7,596.9 points. Four ASX shares that are falling more than most today are listed below. Here's why they...

After we all took a moment to breath easy yesterday with the S&P/ASX 200 (ASX:XJO) p 4.5% for the day, it appears we’re now back to business as usual with the S&P 500 down 3.7% and the Nasdaq 100 down 4.7%. Yesterday’s momentum was...

It’s up and go time for LTR in the US market All the budget healthcare news – and it’s a short item Prescient launches phase 2a study for a rare blood cancer   The developer of a nasal spray-mist erectile dysfunction (ED) treatment, LTR P...

Reproductive technology developed by Memphasys (ASX:MEM) is proving to be a gamechanger in addressing the men’s side of infertility – which is now understood to cause at least half of all conception issues. The company’s Felix™ System ha...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

Morgans analyst Scott Power said this ‘particular reporting season has been one of the worst for a long time’ for ASX healthcare sector ‘Chronic underperformer’ Ramsay Health Care reporting strong performance in its Aussie and UK hospitals...

I believe the ASX small-cap share Monash IVF Group Ltd (ASX: MVF) has a lot of return potential. As its name suggests, it is one of the largest assisted reproduction businesses in Australia. It also has operations related to women's i...

Highlights:  ASX 200 futures signal rebound: Futures up 55 points or 0.69%, indicating the ASX 200 may end its three-day losing streak.  Tech-led rally boosts Wall Street: S&P 500 posted its best session since June, led by gains in...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

This seems like an excellent time to pick up discounted ASX dividend shares while high interest rates have pushed down on the valuations of certain sectors. I'm going to talk about two stocks with share prices under $2. While the share p...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

Are you on the lookout for some new additions to your portfolio in December? If you are, it could pay to look at the two ASX 300 shares that brokers have just put buy ratings on. Here's what they are saying about them: Monash IVF Group Ltd...

The ASX healthcare share Monash IVF Group Ltd (ASX: MVF) could be an underrated ASX dividend share, in my eyes. If we look at the chart below, we can see that Monash IVF briefly touched a 52-week low of $1.11 yesterday. In the last...